Ben Friedman is listed as a director on 4 SEC Form D filings by 2 issuers between Dec 2013 and Nov 2015: Cell Source, Inc. (New York, NY — biotechnology — 2015; $8.88M reported sold to 62 investors) and CELL SOURCE Ltd (Tel Aviv, Israel (as filed: L3) — biotechnology — 2013; $500K reported sold to 4 investors).
What this means 2 separate companies raised money with this person listed as director, over about 2 years. Across those companies the filings report $9.38M sold in total.
Listed alongside Itamar Shimrat (4 shared filings), Yoram Drucker (4 shared filings), David Zolty (3 shared filings), Dennis Brown (3 shared filings) and Solomon Zolty (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Ben. Each name links to their own page.
All 2 issuers belong to the sponsor group Cell Source (2 issuers, $4.41M reported sold, 2013–2023).
What this means A sponsor group is one team that sets up a new company for each deal. Cell Source has 2 companies on file and $4.41M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 6 bankruptcy cases matching the name listed in Key records below.
What this means 6 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 4 public filings for Ben Friedman and found 4 differences, 1 worth asking the sponsor about: Form D filed 69 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.